Analysis

The investment case for Eli Lilly continues to strengthen, even after the pharmaceutical giant surpassed a $1 trillion market valuation....

Australian rare earths producer Lynas Rare Earths Ltd. is facing intense selling pressure following a severe operational disruption at a...

After two years of uncertainty surrounding one of its most significant assets, Barrick Gold has reached a comprehensive settlement with...

Apple's stock is demonstrating remarkable upward momentum, shattering previous resistance levels as institutional investors build significant positions. This bullish trend...

Adobe shares are navigating a challenging period in 2025, trading near their annual lows amid broader sector weakness. As investors...

Eli Lilly has cemented its leadership in the pharmaceutical industry by becoming the first company in the sector to surpass...

After a challenging November that erased nearly one-third of its value, Robinhood shares have mounted a significant recovery at the...

As the crucial holiday season approaches, United Parcel Service (UPS) finds itself at a pivotal moment. Surprisingly strong results from...

While Healwell AI has reported staggering financial growth, its stock performance tells a contradictory and alarming story. The company's latest...

A compelling battle is unfolding around UnitedHealth Group, presenting investors with a complex puzzle. On one side, politically connected insiders...